Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Cardiovasc Diabetol
; 14: 31, 2015 Mar 10.
Article
in En
| MEDLINE
| ID: mdl-25848912
Full text:
1
Database:
MEDLINE
Main subject:
Vascular Diseases
/
Matrix Metalloproteinase 3
/
Tissue Inhibitor of Metalloproteinase-1
/
Matrix Metalloproteinase 2
/
Diabetes Mellitus, Type 1
/
Matrix Metalloproteinase 10
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Cardiovasc Diabetol
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
ENDOCRINOLOGIA
Year:
2015
Type:
Article